A trial found that J and J's vaccine was 66% effective at preventing moderate to severe cases of covid 19, and it was 100% effective at preventing hospitalizations 28 days after vaccination, the company is developing a second generation vaccine that would target the more transmissible South African variant.
試驗發現,J和J的疫苗對預防中度至重度的科維德19病例有66%的效果,對預防接種後28天的住院治療有100%的效果,該公司正在開發第二代疫苗,該疫苗將針對傳播性更強的南非變種。